BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24009705)

  • 1. Interferon and ribavirin combination treatment synergistically inhibit HCV internal ribosome entry site mediated translation at the level of polyribosome formation.
    Panigrahi R; Hazari S; Chandra S; Chandra PK; Datta S; Kurt R; Cameron CE; Huang Z; Zhang H; Garry RF; Balart LA; Dash S
    PLoS One; 2013; 8(8):e72791. PubMed ID: 24009705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication.
    Wang C; Pflugheber J; Sumpter R; Sodora DL; Hui D; Sen GC; Gale M
    J Virol; 2003 Apr; 77(7):3898-912. PubMed ID: 12634350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system.
    Mori K; Ikeda M; Ariumi Y; Dansako H; Wakita T; Kato N
    Virus Res; 2011 Apr; 157(1):61-70. PubMed ID: 21320556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway.
    Kato J; Kato N; Moriyama M; Goto T; Taniguchi H; Shiratori Y; Omata M
    J Infect Dis; 2002 Jul; 186(2):155-63. PubMed ID: 12134250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PKR-dependent mechanisms of gene expression from a subgenomic hepatitis C virus clone.
    Rivas-Estilla AM; Svitkin Y; Lopez Lastra M; Hatzoglou M; Sherker A; Koromilas AE
    J Virol; 2002 Nov; 76(21):10637-53. PubMed ID: 12368306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus IRES-dependent translation is insensitive to an eIF2alpha-independent mechanism of inhibition by interferon in hepatocyte cell lines.
    Koev G; Duncan RF; Lai MM
    Virology; 2002 Jun; 297(2):195-202. PubMed ID: 12083818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tricistronic hepatitis C virus subgenomic replicon expressing double transgenes.
    Cheng X; Gao XC; Wang JP; Yang XY; Wang Y; Li BS; Kang FB; Li HJ; Nan YM; Sun DX
    World J Gastroenterol; 2014 Dec; 20(48):18284-95. PubMed ID: 25561795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System.
    Aboulnasr F; Hazari S; Nayak S; Chandra PK; Panigrahi R; Ferraris P; Chava S; Kurt R; Song K; Dash A; Balart LA; Garry RF; Wu T; Dash S
    PLoS One; 2015; 10(12):e0141655. PubMed ID: 26657215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regulation of hepatitis C virus (HCV) internal ribosome-entry site-mediated translation by HCV replicons and nonstructural proteins.
    He Y; Yan W; Coito C; Li Y; Gale M; Katze MG
    J Gen Virol; 2003 Mar; 84(Pt 3):535-543. PubMed ID: 12604803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.
    Dash S; Prabhu R; Hazari S; Bastian F; Garry R; Zou W; Haque S; Joshi V; Regenstein FG; Thung SN
    Liver Int; 2005 Jun; 25(3):580-94. PubMed ID: 15910496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis.
    François C; Duverlie G; Rebouillat D; Khorsi H; Castelain S; Blum HE; Gatignol A; Wychowski C; Moradpour D; Meurs EF
    J Virol; 2000 Jun; 74(12):5587-96. PubMed ID: 10823866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eukaryotic initiation factor 5B: a new player for the anti-hepatitis C virus effect of ribavirin?
    Galmozzi E; Aghemo A; Colombo M
    Med Hypotheses; 2012 Oct; 79(4):471-3. PubMed ID: 22824093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribavirin up-regulates the activity of double-stranded RNA-activated protein kinase and enhances the action of interferon-alpha against hepatitis C virus.
    Liu WL; Su WC; Cheng CW; Hwang LH; Wang CC; Chen HL; Chen DS; Lai MY
    J Infect Dis; 2007 Aug; 196(3):425-34. PubMed ID: 17597457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of internal ribosomal entry site-directed translation of HCV by recombinant IFN-alpha correlates with a reduced La protein.
    Shimazaki T; Honda M; Kaneko S; Kobayashi K
    Hepatology; 2002 Jan; 35(1):199-208. PubMed ID: 11786977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between translation efficiency and outcome of combination therapy in chronic hepatitis C genotype 3.
    Yasmeen A; Hamid S; Granath FN; Lindström H; Elliott RM; Siddiqui AA; Persson MA
    J Viral Hepat; 2006 Feb; 13(2):87-95. PubMed ID: 16436126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence-specific cleavage of hepatitis C virus RNA by DNAzymes: inhibition of viral RNA translation and replication.
    Roy S; Gupta N; Subramanian N; Mondal T; Banerjea AC; Das S
    J Gen Virol; 2008 Jul; 89(Pt 7):1579-1586. PubMed ID: 18559927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of IRES containing 5'UTR of HCV genotype 3a using siRNAs.
    Khaliq S; Jahan S; Pervaiz A; Ali Ashfaq U; Hassan S
    Virol J; 2011 May; 8():221. PubMed ID: 21569449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.
    Marcello T; Grakoui A; Barba-Spaeth G; Machlin ES; Kotenko SV; MacDonald MR; Rice CM
    Gastroenterology; 2006 Dec; 131(6):1887-98. PubMed ID: 17087946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinations of 2'-C-methylcytidine analogues with interferon-alpha2b and triple combination with ribavirin in the hepatitis C virus replicon system.
    Bassit L; Grier J; Bennett M; Schinazi RF
    Antivir Chem Chemother; 2008; 19(1):25-31. PubMed ID: 18610555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha.
    Tanabe Y; Sakamoto N; Enomoto N; Kurosaki M; Ueda E; Maekawa S; Yamashiro T; Nakagawa M; Chen CH; Kanazawa N; Kakinuma S; Watanabe M
    J Infect Dis; 2004 Apr; 189(7):1129-39. PubMed ID: 15031779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.